In this power packed episode, Phil Bergman is back again on the show this time talking about exciting developments in veterinary medicine and oncology. We had Dr. Bergman on Season 1 as his role as Director of Clinical Studies for VCA and back then he wanted talk about a ground breaking trial underway. Gilvetmab is a game changer and a new class of cancer drugs called Checkpoint Inhibitors.
Phil also shares his excitement for the upcoming launch of Librela, the monoclonal antibody therapy from Zoetis for canine osteoarthritis.
--------
#FuzzbuttsAndFriends #yerbigdog #lukerobinson #gingermorgan #PhilBergman #VCA #Gilvetmab #MerckAnimalHealth #caninecancer #Librela #Zoetis #osteoarthritis #PuppyUp
